Targeted Markets Small to mid-size biomedical and life sciences customers seeking MEMS-based Lab-on-Chip solutions present a clear upsell path for Micropoint Biotechnologies, especially given their focus on customized, cost-effective devices.

Expansion Potential With revenue in the low to mid single digits and a lean team, there is room to scale via outsourcing partnerships, contract manufacturing, and collaborative R&D programs with larger pharma and diagnostic players.

Technology Differentiation Emphasize MEMS-based Lab-on-Chip expertise and microfluidics capability as a competitive edge to win early-stage diagnostics, point-of-care, and research tools segments that require compact, integrated systems.

Digital Presence The current tech stack and web footprint indicate opportunities to augment digital marketing, e-commerce-friendly product pages, and partner portals to capture inbound inquiries from researchers and device integrators.

Strategic Partnerships Forge alliances with larger contract manufacturers or distributors in life sciences to accelerate scale, access new geographies, and qualify Micropoint’s custom solutions for broader procurement programs.